Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2013 Will be a Banner Year for GeoVax
Yahoo/Zacks
Monday, May 6, 2013 - 10:51am
tags:
GeoVax, earnings
FDA Will Find Docs Still Detest DTC Advertising: Survey
Pharmalot
Monday, May 6, 2013 - 10:49am
tags:
FDA, DTC, physicians
Netupitant Results Could Roil Tesaro In May
Seeking Alpha
Monday, May 6, 2013 - 10:48am
tags:
Tesaro, Netupitant, breast cancer, ovarian cancer, niraparib, Sanofi, Roche, OPKO Health, Merck, GSK, Eisai
Pfizer to start selling Viagra online
CNN Money
Monday, May 6, 2013 - 10:43am
tags:
Pfizer, Viagra
Cost Cutting Initiative to Bolster GlaxoSmithKline's Earnings
Motley Fool
Monday, May 6, 2013 - 10:23am
tags:
earnings, GSK
[video]Are Obesity Drugs a Lost Cause in Europe?
Motley Fool
Monday, May 6, 2013 - 9:20am
tags:
obesity, Europe, Vivus, Arena Pharmaceuticals, Qsymia, Belviq
Even Pharma's Good Deeds Are Criticized
Forbes
Monday, May 6, 2013 - 9:16am
tags:
pharma industry, philanthropy
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Monday, May 6, 2013 - 9:12am
tags:
kidney cancer, ONYX Pharmaceuticals, Bayer, Nexavar, Roche, Avastin, Inlyta, Sutent, Pfizer, Votrient, GSK, Afinitor, Novartis, BMS-936558, Bristol-Myers Squibb, tivozanib, Aveo Oncology
Novartis Boost Seen in Fast Approvals as Protection Ends
Bloomberg
Monday, May 6, 2013 - 9:08am
tags:
drug approvals, Novartis, LDK378, lung cancer
Teva Pharmaceutical Industries Hits Estimates, But GAAP Results Lag Last Year's
Daily Finance
Sunday, May 5, 2013 - 11:09am
tags:
Teva, earnings
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Pharmabiz
Sunday, May 5, 2013 - 11:07am
tags:
Raptor Pharmaceuticals, procysbi, nephropathic cystinosis
Pfizer’s Big Studies and Top Stories Affecting Dow 30 Healthcare This Week
Wall Street Cheat Street
Sunday, May 5, 2013 - 11:03am
tags:
Pfizer, Merck, JNJ
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sunday, May 5, 2013 - 11:00am
tags:
Bristol-Myers Squibb, nivolumab, BMS-936558, non-small cell lung cancer, renal cell carcinoma, melanoma, Ono Pharmaceutical, tivozanib, Aveo Pharmaceuticals, elotuzumab
3 Promising Treatments for a Surprisingly Common Health Problem
Motley Fool
Sunday, May 5, 2013 - 10:54am
tags:
MK-7243, allergic rhinitis, allergies, Ragweed Allergy, Merck, MK-3461, ALK-Abello
AVEO: Here's Looking At You, FDA
Seeking Alpha
Sunday, May 5, 2013 - 10:48am
tags:
Aveo Pharmaceuticals, tivozanib, renal cell carcinoma
2 Biotechs To Avoid, 1 To Buy
Motley Fool
Sunday, May 5, 2013 - 10:46am
tags:
Aveo Pharmaceuticals, InterMune, Galena Biopharma
It's Pipeline That Matters Most
The Street
Saturday, May 4, 2013 - 11:05am
tags:
Merck, Allergan, JNJ
Neurocrine Biosciences CEO Discuses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 4, 2013 - 11:03am
tags:
Neurocrine Biosciences, earnings
FDA approves J&J sedation drug device
Reuters
Saturday, May 4, 2013 - 11:02am
tags:
JNJ, Sedasys, propofol
Why Investors Shouldn't Worry About Sanofi's Poor Quarter
Motley Fool
Saturday, May 4, 2013 - 10:50am
tags:
Sanofi, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.